BOSENTAN and MALAISE

Overview

MALAISE is the #11 most commonly reported adverse reaction for BOSENTAN, manufactured by Actelion Pharmaceuticals US, Inc.. There are 1,692 FDA adverse event reports linking BOSENTAN to MALAISE. This represents approximately 1.7% of all 98,401 adverse event reports for this drug.

Patients taking BOSENTAN who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

MALAISE is a less commonly reported adverse event for BOSENTAN, but still significant enough to appear in the safety profile.

Other Side Effects of BOSENTAN

In addition to malaise, the following adverse reactions have been reported for BOSENTAN:

• DEATH — 9,291 reports
• DYSPNOEA — 5,974 reports
• PNEUMONIA — 2,684 reports
• PULMONARY ARTERIAL HYPERTENSION — 2,291 reports
• FATIGUE — 2,232 reports
• HEADACHE — 2,202 reports
• NAUSEA — 2,053 reports
• DIARRHOEA — 1,968 reports
• CONDITION AGGRAVATED — 1,868 reports
• DIZZINESS — 1,762 reports

Other Drugs Associated with MALAISE

The following drugs have also been linked to malaise in FDA adverse event reports:

Does BOSENTAN cause MALAISE?

MALAISE has been reported as an adverse event in 1,692 FDA reports for BOSENTAN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is MALAISE with BOSENTAN?

MALAISE accounts for approximately 1.7% of all adverse event reports for BOSENTAN, making it a notable side effect.

What should I do if I experience MALAISE while taking BOSENTAN?

If you experience malaise while taking BOSENTAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages